Literature DB >> 16391231

Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.

Roger A Greenberg1, Bijan Sobhian, Shailja Pathania, Sharon B Cantor, Yoshihiro Nakatani, David M Livingston.   

Abstract

The BRCA1 gene product and its stoichiometric binding partner, BARD1, play a vital role in the cellular response to DNA damage. However, how they acquire specific biochemical functions after DNA damage is poorly understood. Following exposure to genotoxic stress, DNA damage-specific interactions were observed between BRCA1/BARD1 and the DNA damage-response proteins, TopBP1 and Mre11/Rad50/NBS1. Two distinct DNA damage-dependent super complexes emerged; their activation was dependent, in part, on the actions of specific checkpoint kinases, and each super complex contributed to a distinctive aspect of the DNA damage response. The results support a new, multifactorial model that describes how genotoxic stress enables BRCA1 to execute a diverse set of DNA damage-response functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391231      PMCID: PMC1356099          DOI: 10.1101/gad.1381306

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  61 in total

1.  Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.

Authors:  Seong-Tae Kim; Bo Xu; Michael B Kastan
Journal:  Genes Dev       Date:  2002-03-01       Impact factor: 11.361

2.  BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.

Authors:  Ronit I Yarden; Sherly Pardo-Reoyo; Magda Sgagias; Kenneth H Cowan; Lawrence C Brody
Journal:  Nat Genet       Date:  2002-02-11       Impact factor: 38.330

3.  Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.

Authors:  Bo Xu; Anne H O'Donnell; Seong-Tae Kim; Michael B Kastan
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

4.  The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients.

Authors:  Stephen J Elledge; Angelika Amon
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

5.  BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.

Authors:  Rachel Litman; Min Peng; Zhe Jin; Fan Zhang; Junran Zhang; Simon Powell; Paul R Andreassen; Sharon B Cantor
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

6.  Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation.

Authors:  Bo Xu; Seong-Tae Kim; Dae-Sik Lim; Michael B Kastan
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

7.  The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.

Authors:  Jacob Falck; John H J Petrini; Bret R Williams; Jiri Lukas; Jiri Bartek
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

Review 8.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

9.  Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.

Authors:  Sang Soo Kim; Liu Cao; Cuiling Li; Xiaoling Xu; L Julie Huber; Lewis A Chodosh; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Biallelic inactivation of BRCA2 in Fanconi anemia.

Authors:  Niall G Howlett; Toshiyasu Taniguchi; Susan Olson; Barbara Cox; Quinten Waisfisz; Christine De Die-Smulders; Nicole Persky; Markus Grompe; Hans Joenje; Gerard Pals; Hideyuki Ikeda; Edward A Fox; Alan D D'Andrea
Journal:  Science       Date:  2002-06-13       Impact factor: 47.728

View more
  169 in total

1.  Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.

Authors:  Kumar Somyajit; Shreelakshmi Subramanya; Ganesh Nagaraju
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  A BRCA1-interacting lncRNA regulates homologous recombination.

Authors:  Vivek Sharma; Simran Khurana; Nard Kubben; Kotb Abdelmohsen; Philipp Oberdoerffer; Myriam Gorospe; Tom Misteli
Journal:  EMBO Rep       Date:  2015-09-27       Impact factor: 8.807

3.  Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes.

Authors:  Hisham Mohammed; Christopher Taylor; Gordon D Brown; Evaggelia K Papachristou; Jason S Carroll; Clive S D'Santos
Journal:  Nat Protoc       Date:  2016-01-21       Impact factor: 13.491

Review 4.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

5.  BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

Authors:  Xiaochun Yu; Shuang Fu; Maoyi Lai; Richard Baer; Junjie Chen
Journal:  Genes Dev       Date:  2006-07-01       Impact factor: 11.361

6.  BRCA mutations and childhood cancer.

Authors:  Roger A Greenberg
Journal:  Cancer Biol Ther       Date:  2006-09-24       Impact factor: 4.742

7.  RAP80 protein is important for genomic stability and is required for stabilizing BRCA1-A complex at DNA damage sites in vivo.

Authors:  Jiaxue Wu; Chao Liu; Junjie Chen; Xiaochun Yu
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

8.  Pyrimidine base damage is increased in women with BRCA mutations.

Authors:  Edwin E Budzinski; Helen B Patrzyc; Jean B Dawidzik; Harold G Freund; Peter Frederick; Heidi E Godoy; Nicoleta C Voian; Kunle Odunsi; Harold C Box
Journal:  Cancer Lett       Date:  2013-04-11       Impact factor: 8.679

9.  Breast cancer gene variants: separating the harmful from the harmless.

Authors:  Susan M Domchek; Roger A Greenberg
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 10.  Mechanisms of BRCA1 tumor suppression.

Authors:  Daniel P Silver; David M Livingston
Journal:  Cancer Discov       Date:  2012-07-27       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.